The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014
- PMID: 28701467
- PMCID: PMC5585695
- DOI: 10.1128/CVI.00142-17
The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014
Abstract
The development of a functional biomarker assay in the tuberculosis (TB) field would be widely recognized as a major advance in efforts to develop and to test novel TB vaccine candidates efficiently. We present preliminary studies using mycobacterial growth inhibition assays (MGIAs) to detect Mycobacterium bovis BCG vaccine responses across species, and we extend this work to determine whether a standardized MGIA can be applied in characterizing new TB vaccines. The comparative MGIA studies reviewed here aimed to evaluate robustness, reproducibility, and ability to reflect in vivo responses. In doing so, they have laid the foundation for the development of a MGIA that can be standardized and potentially qualified. A major challenge ahead lies in better understanding the relationships between in vivo protection, in vitro growth inhibition, and the immune mechanisms involved. The final outcome would be a MGIA that could be used with confidence in TB vaccine trials. We summarize data arising from this project, present a strategy to meet the goals of developing a functional assay for TB vaccine testing, and describe some of the challenges encountered in performing and transferring such assays.
Keywords: MGIA; correlates of immunity; mycobacterial growth inhibition assay; tuberculosis; vaccines.
Copyright © 2017 Brennan et al.
Figures


















Similar articles
-
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection.Front Immunol. 2020 Jan 10;10:2983. doi: 10.3389/fimmu.2019.02983. eCollection 2019. Front Immunol. 2020. PMID: 31998295 Free PMC article.
-
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.BMC Infect Dis. 2016 Aug 12;16:412. doi: 10.1186/s12879-016-1751-4. BMC Infect Dis. 2016. PMID: 27519524 Free PMC article.
-
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development.Tuberculosis (Edinb). 2017 Sep;106:118-122. doi: 10.1016/j.tube.2017.07.008. Epub 2017 Jul 22. Tuberculosis (Edinb). 2017. PMID: 28802398 Free PMC article.
-
Development and application of the direct mycobacterial growth inhibition assay: a systematic review.Front Immunol. 2024 Feb 6;15:1355983. doi: 10.3389/fimmu.2024.1355983. eCollection 2024. Front Immunol. 2024. PMID: 38380319 Free PMC article.
-
In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy.Vaccine. 2016 Sep 7;34(39):4656-4665. doi: 10.1016/j.vaccine.2016.07.058. Epub 2016 Aug 12. Vaccine. 2016. PMID: 27527814 Review.
Cited by
-
Impact of selective immune-cell depletion on growth of Mycobacterium tuberculosis (Mtb) in a whole-blood bactericidal activity (WBA) assay.PLoS One. 2019 May 17;14(5):e0216616. doi: 10.1371/journal.pone.0216616. eCollection 2019. PLoS One. 2019. PMID: 31100071 Free PMC article.
-
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection.Front Immunol. 2020 Jan 10;10:2983. doi: 10.3389/fimmu.2019.02983. eCollection 2019. Front Immunol. 2020. PMID: 31998295 Free PMC article.
-
Immunological mechanisms of tuberculosis susceptibility in TB-infected individuals with type 2 diabetes mellitus: insights from mycobacterial growth inhibition assay and cytokine analysis.Microbiol Spectr. 2025 Jan 7;13(1):e0144524. doi: 10.1128/spectrum.01445-24. Epub 2024 Dec 10. Microbiol Spectr. 2025. PMID: 39656000 Free PMC article.
-
An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes.Front Pediatr. 2019 Apr 30;7:151. doi: 10.3389/fped.2019.00151. eCollection 2019. Front Pediatr. 2019. PMID: 31114771 Free PMC article.
-
Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity.Front Immunol. 2019 Nov 1;10:2479. doi: 10.3389/fimmu.2019.02479. eCollection 2019. Front Immunol. 2019. PMID: 31736945 Free PMC article.
References
-
- Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, Matsumiya M, Tanner R, O'Shea MK, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Manjaly-Thomas ZR, Naranbhai V, Stylianou E, Darboe F, Penn-Nicholson A, Nemes E, Hatheril M, Hussey G, Mahomed H, Tameris M, McClain JB, Evans TG, Hanekom WA, Scriba TJ, McShane H. 2016. T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nat Commun 7:11290. doi:10.1038/ncomms11290. - DOI - PMC - PubMed
-
- Fletcher HA, Filali-Mouhim A, Nemes E, Hawkridge A, Keyser A, Njikan S, Hatherill M, Scriba TJ, Abel B, Kagina BM, Veldsman A, Agudelo NM, Kaplan G, Hussey GD, Sekaly RP, Hanekom WA. 2016. Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study. BMC Med 14:76. doi:10.1186/s12916-016-0617-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources